A new report concludes that if Vermont undertakes wholesale importation of prescription drugs from Canada, such a program could achieve cost savings for the state’s commercial payers. An increasing number of states are mulling over Canadian drug importation, some looking to Vermont and its enacted legislation as they explore the issue. But achieving benefits requires an emphasis on program mechanics, and Vermont’s own effort is far from a done deal — with the state’s largest health insurer pointing out that administrative costs and hurdles, which may be significant, are not quantified in this feasibility study.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.